Pregnancy Outcomes and Child Development Effects of SARS-CoV-2 Infection (PROUDEST Trial): Protocol for a Multicenter, Prospective Cohort Study.

Autor:	Fernandes GM; Faculty of Medicine, University of Brasília, Brasília - DF, Brazil., Motta F; Faculty of Medicine, University of Brasília, Brasília - DF, Brazil., Sasaki LMP; Faculty of Medicine, University of Brasília, Brasília - DF, Brazil., Silva ÂPD; Department of Rheumatology, University Hospital of Brasília, Brasília, Brazil., Miranda AM; State Health Department of the Federal District, Brasília, Brazil., Carvalho AO; Department of Rheumatology, University Hospital of Brasília, Brasília, Brazil., Gomides APM; Faculty of Medicine, University Center of Brasília, Brasília, Brazil., Soares AASM; Faculty of Medicine, University of Brasília, Brasília - DF, Brazil., Santos ACMD Jr; Central Laboratory of Public Health of the Federal District, Brasília, Brazil., Alves CO; Faculty of Medicine, University of Brasília, Brasília - DF, Brazil., Gomes CM; Faculty of Medicine, University of Brasília, Brasília - DF, Brazil., Siracusa CC; Faculty of Medicine, University of Brasília, Brasília - DF, Brazil., Araújo DA Jr; Department of Rheumatology, University Hospital of Brasília, Brasília, Brazil., Mendonça-Silva DL; Department of Rheumatology, University Hospital of Brasília, Brasília, Brazil., Jesus JAL; Faculty of Medicine, University of Brasília, Brasília - DF, Brazil., Costa KN; Faculty of Medicine, University of Brasília, Brasília - DF, Brazil., Castro MEC; Department of Rheumatology, University Hospital of Brasília, Brasília, Brazil., Kurizky PS; Department of Rheumatology, University Hospital of Brasília, Brasília, Brazil., França PS; Faculty of Medicine, University of Brasília, Brasília - DF, Brazil., Tristão R; Faculty of Medicine, University of Brasília, Brasília - DF, Brazil., Pereira YR; Department of Rheumatology, University Hospital of Brasília, Brasília, Brazil., Castro LCG; Faculty of Medicine, University of Brasília, Brasília - DF, Brazil., Zaconeta AM; Faculty of Medicine, University of Brasília, Brasília - DF, Brazil., Albuquerque CP; Department of Rheumatology, University Hospital of Brasília, Brasília, Brazil., Mota LMHD; Faculty of Medicine, University of Brasília, Brasília - DF, Brazil.
Jazyk:	angličtina
Zdroj:	JMIR research protocols [JMIR Res Protoc] 2021 Apr 20; Vol. 10 (4), pp. e26477. Date of Electronic Publication: 2021 Apr 20.
DOI:	10.2196/26477
Abstrakt:	Background: A growing body of evidence suggests that SARS-COV-2 infection during pregnancy may affect maternal-fetal outcomes and possibly result in implications for the long-term development of SARS-CoV-2-exposed children. Objective: The PROUDEST (Pregnancy Outcomes and Child Development Effects of SARS-CoV-2 Infection Study) is a multicenter, prospective cohort study designed to elucidate the repercussions of COVID-19 for the global health of mothers and their children. Methods: The PROUDEST trial comprises 2 prospective, sequential substudies. The PREGNANT substudy will clinically assess the effects of SARS-CoV-2 infection on pregnancy, childbirth, and puerperium from a mechanistic standpoint to elucidate the pregnancy-related inflammatory and immunological phenomena underlying COVID-19. Pregnant women aged 18-40 years who have been exposed (proven with laboratory tests) to SARS-CoV-2 (group A; n=300) will be compared to control subjects with no laboratory evidence of in-pregnancy exposure to the virus (group B; n=300). Subjects exposed to other infections during pregnancy will be excluded. The BORN substudy is a long-term follow-up study that will assess the offspring of women who enrolled in the prior substudy. It will describe the effects of SARS-CoV-2 exposure during pregnancy on children's growth, neurodevelopment, and metabolism from birth up to 5 years of age. It includes two comparison groups; group A (exposed; n=300) comprises children born from SARS-CoV-2-exposed pregnancies, and group B (controls; n=300) comprises children born from nonexposed mothers. Results: Recruitment began in July 2020, and as of January 2021, 260 pregnant women who were infected with SARS-CoV-2 during pregnancy and 160 newborns have been included in the study. Data analysis is scheduled to start after all data are collected. Conclusions: Upon completion of the study, we expect to have comprehensive data that will provide a better understanding of the effects of SARS-CoV-2 infection and related inflammatory and immunological processes on pregnancy, puerperium, and infancy. Our findings will inform clinical decisions regarding the care of SARS-CoV-2-exposed mothers and children and support the development of evidence-based public health policies. Trial Registration: Brazilian Register of Clinical Trials RBR65QXS2; https://ensaiosclinicos.gov.br/rg/RBR-65qxs2. International Registered Report Identifier (irrid): DERR1-10.2196/26477. (©Geraldo Magela Fernandes, Felipe Motta, Lizandra Moura Paravidine Sasaki, Ângelo Pereira Da Silva, Andreza Monforte Miranda, Aleida Oliveira De Carvalho, Ana Paula Monteiro Gomides, Alexandre Anderson De Sousa Munhoz Soares, Agenor De Castro Moreira Dos Santos Jr, Caroline De Oliveira Alves, Ciro Martins Gomes, Clara Correia De Siracusa, David Alves De Araújo Jr, Dayde Lane Mendonça-Silva, José Alfredo Lacerda De Jesus, Karina Nascimento Costa, Maria Eduarda Canellas De Castro, Patricia Shu Kurizky, Paulo Sérgio França, Rosana Tristão, Yacara Ribeiro Pereira, Luiz Claudio Gonçalves De Castro, Alberto Moreno Zaconeta, Cleandro Pires De Albuquerque, Licia Maria Henrique Da Mota. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 20.04.2021.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu